Abyrx
About:
Abyrx develops, manufactures, and provides specialty biosurgical products for use during surgical procedures
Website: http://www.abyrx.com/
Twitter/X: abyrx
Top Investors: Canaan Partners, BB Biotech Ventures, MedEdge
Description:
Abyrx acquisition of the HEMASORB Resorbable Hemostatic Bone Putty portfolio and the right to develop Bezwada Biomedical’s polymer technology for bone applications. The Company develops, manufactures, and provides therapeutic devices for use during surgical procedures.
Total Funding Amount:
$10M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Irvington, New York, United States
Founded Date:
2013-01-01
Contact Email:
info(AT)abyrx.com
Founders:
John J. Pacifico
Number of Employees:
11-50
Last Funding Date:
2016-12-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai